ArticleNeurology and therapy2022

Pharmacokinetics of XEN496, a Novel Pediatric Formulation of Ezogabine, Under Fed and Fasted Conditions: A Phase 1 Trial.

Rostam Namdari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.